KeyCorp Increases Integer (NYSE:ITGR) Price Target to $144.00

Integer (NYSE:ITGR) had its target price increased by equities research analysts at KeyCorp from $139.00 to $144.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “overweight” rating on the medical equipment provider’s stock. KeyCorp’s price objective suggests a potential upside of 9.87% from the stock’s previous close.

Several other equities research analysts also recently issued reports on the company. Truist Financial raised their price target on Integer from $145.00 to $150.00 and gave the company a “buy” rating in a report on Monday. Citigroup lifted their target price on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Oppenheimer began coverage on shares of Integer in a report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target on the stock. Bank of America boosted their price objective on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Finally, Benchmark reiterated a “buy” rating and set a $130.00 target price on shares of Integer in a research note on Wednesday, October 2nd. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $138.71.

Integer Stock Performance

Shares of ITGR opened at $131.06 on Tuesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a 50-day moving average of $126.20 and a 200-day moving average of $120.41. The company has a market cap of $4.39 billion, a PE ratio of 45.35, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. Integer has a one year low of $69.40 and a one year high of $133.53.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm had revenue of $436.20 million for the quarter, compared to the consensus estimate of $437.00 million. During the same quarter in the previous year, the business earned $1.14 earnings per share. The business’s revenue was up 9.0% compared to the same quarter last year. As a group, equities analysts forecast that Integer will post 5.3 earnings per share for the current year.

Insiders Place Their Bets

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now owns 2,280 shares in the company, valued at $272,824.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in ITGR. Driehaus Capital Management LLC grew its position in shares of Integer by 62.5% during the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after purchasing an additional 135,750 shares in the last quarter. F M Investments LLC acquired a new stake in shares of Integer during the 2nd quarter worth approximately $11,143,000. Point72 Europe London LLP acquired a new stake in shares of Integer during the 2nd quarter worth approximately $6,241,000. Earnest Partners LLC boosted its position in shares of Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after acquiring an additional 37,340 shares in the last quarter. Finally, Congress Asset Management Co. MA boosted its position in shares of Integer by 7.5% during the 1st quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock worth $52,886,000 after acquiring an additional 31,736 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.